Clinical Experience with Intravenous zanamivir correspondence under an emergency investigational new drug program in the United States
Chan-Taik KM, Himaya AC, Thompson EG, et al. Clinical Experience with Intravenous zanamivir correspondence under an emergency investigational new drug program in the United States. J Infect Dis 2013; 207:196-8.
Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza a (H1N1) infection
Fraaij PL, van der Vries E, Beersma MF, et al. Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza a (H1N1) infection. J Infect Dis 2011; 204:777-82.
Oseltamivir- resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010
Meijer A, Jonges M, Abbink F, et al. Oseltamivir- resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010. Antiviral Res 2011; 92:81-9.
Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1) v
Petersen E, Keld DB, Ellermann-Eriksen S, et al. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1) v. Scand J Infect Dis 2011; 43:495-503.
Davies A, Jones D, Bailey M, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009; 302:1888-95.
Use of intravenous peramivir for treatment of severe influenza A (H1N1)pdm09
Louie JK, Yang S, Yen C, Acosta M, Schechter R, Uyeki TM. Use of intravenous peramivir for treatment of severe influenza A (H1N1)pdm09. PLoS One 2012; 7:e40261.
